Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2016 2
2017 2
2018 1
2019 1
2021 4
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Promises and challenges of adoptive T-cell therapies for solid tumours.
Morotti M, Albukhari A, Alsaadi A, Artibani M, Brenton JD, Curbishley SM, Dong T, Dustin ML, Hu Z, McGranahan N, Miller ML, Santana-Gonzalez L, Seymour LW, Shi T, Van Loo P, Yau C, White H, Wietek N, Church DN, Wedge DC, Ahmed AA. Morotti M, et al. Among authors: albukhari a. Br J Cancer. 2021 May;124(11):1759-1776. doi: 10.1038/s41416-021-01353-6. Epub 2021 Mar 29. Br J Cancer. 2021. PMID: 33782566 Free PMC article. Review.
Mechanistic Drivers of Müllerian Duct Development and Differentiation Into the Oviduct.
Santana Gonzalez L, Rota IA, Artibani M, Morotti M, Hu Z, Wietek N, Alsaadi A, Albukhari A, Sauka-Spengler T, Ahmed AA. Santana Gonzalez L, et al. Among authors: albukhari a. Front Cell Dev Biol. 2021 Mar 8;9:605301. doi: 10.3389/fcell.2021.605301. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33763415 Free PMC article. Review.
The sensitivity of Na+, K+ ATPase as an indicator of blood diseases.
Omar AK, Ahmed KA, Helmi NM, Abdullah KT, Qarii MH, Hasan HE, Ashwag A, Nabil AM, Abdu AM, Salama MS. Omar AK, et al. Among authors: ashwag a. Afr Health Sci. 2017 Mar;17(1):262-269. doi: 10.4314/ahs.v17i1.32. Afr Health Sci. 2017. PMID: 29026401 Free PMC article.
Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor-initiating cells.
Artibani M, Masuda K, Hu Z, Rauher PC, Mallett G, Wietek N, Morotti M, Chong K, KaramiNejadRanjbar M, Zois CE, Dhar S, El-Sahhar S, Campo L, Blagden SP, Damato S, Pathiraja PN, Nicum S, Gleeson F, Laios A, Alsaadi A, Santana Gonzalez L, Motohara T, Albukhari A, Lu Z, Bast RC Jr, Harris AL, Ejsing CS, Klemm RW, Yau C, Sauka-Spengler T, Ahmed AA. Artibani M, et al. Among authors: albukhari a. JCI Insight. 2021 Jun 8;6(11):e147929. doi: 10.1172/jci.insight.147929. JCI Insight. 2021. PMID: 33945502 Free PMC article.
Author Correction: Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylation.
Zheng Y, Sethi R, Mangala LS, Taylor C, Goldsmith J, Wang M, Masuda K, Carrami EM, Mannion D, Miranda F, Herrero-Gonzalez S, Hellner K, Chen F, Alsaadi A, Albukhari A, Fotso DC, Yau C, Jiang D, Pradeep S, Rodriguez-Aguayo C, Lopez-Berestein G, Knapp S, Gray NS, Campo L, Myers KA, Dhar S, Ferguson D, Bast RC Jr, Sood AK, von Delft F, Ahmed AA. Zheng Y, et al. Among authors: albukhari a. Nat Commun. 2022 Jun 10;13(1):3352. doi: 10.1038/s41467-022-31011-1. Nat Commun. 2022. PMID: 35688808 Free PMC article. No abstract available.
Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylation.
Zheng Y, Sethi R, Mangala LS, Taylor C, Goldsmith J, Wang M, Masuda K, Carrami EM, Mannion D, Miranda F, Herrero-Gonzalez S, Hellner K, Chen F, Alsaadi A, Albukhari A, Fotso DC, Yau C, Jiang D, Pradeep S, Rodriguez-Aguayo C, Lopez-Berestein G, Knapp S, Gray NS, Campo L, Myers KA, Dhar S, Ferguson D, Bast RC Jr, Sood AK, von Delft F, Ahmed AA. Zheng Y, et al. Among authors: albukhari a. Nat Commun. 2018 Feb 2;9(1):476. doi: 10.1038/s41467-017-02811-7. Nat Commun. 2018. PMID: 29396402 Free PMC article.
The Oxford Classic Links Epithelial-to-Mesenchymal Transition to Immunosuppression in Poor Prognosis Ovarian Cancers.
Hu Z, Cunnea P, Zhong Z, Lu H, Osagie OI, Campo L, Artibani M, Nixon K, Ploski J, Santana Gonzalez L, Alsaadi A, Wietek N, Damato S, Dhar S, Blagden SP, Yau C, Hester J, Albukhari A, Aboagye EO, Fotopoulou C, Ahmed A. Hu Z, et al. Among authors: albukhari a. Clin Cancer Res. 2021 Mar 1;27(5):1570-1579. doi: 10.1158/1078-0432.CCR-20-2782. Epub 2021 Jan 14. Clin Cancer Res. 2021. PMID: 33446563
POSSIBLE REGULATION OF LDL-RECEPTOR BY NARINGENIN IN HEPG2 HEPATOMA CELL LINE.
Bawazeer NA, Choudary H, Zamzami MA, Abdulaal WH, Zeyadi M, ALbukhari A, Middleton B, Moselhy SS. Bawazeer NA, et al. Among authors: albukhari a. Afr J Tradit Complement Altern Med. 2016 Nov 23;14(1):278-287. doi: 10.21010/ajtcam.v14i1.30. eCollection 2017. Afr J Tradit Complement Altern Med. 2016. PMID: 28480406 Free PMC article.
12 results